Table 1.

Hormonal evaluation of CDG females from previous studies and our patient*.

	Ia [9]	Ia [9]	Ic [8]	Ic*
D4A	77 ng/dL (72–143)	89 ng/dL (72–143)	201, 234 ng/dL (60–245)	101, 180, 200 ng/dL (50–430)
DHEA-S	169 mcg/dL (48–239)	206 mcg/dL (48–239)	38 mcg/dL (60–255)	81, 168, 216 mcg/dL (35–430)
17-OHP			42 ng/dL (15–70)	39 ng/dL (20–170)
T	74.5 ng/dL (b74.5)	109.5 ng/dL (b74.5)	76, 101 ng/dL (10–55)	36, 46, 47 ng/dL (14–75)
Free T			14, 16 pg/mL (1.1–6.3)	11 pg/mL (1–15)
SHBG			0.7, 1.0, 1.1 mcg/dL (1.0–3.0)	0.9 mcg/dL (0.9–3.9)
LH	↑	↑	2.4, 1.1 IU/L (2–15 F, 0.6–19 L)	2.5, 3.4, 3.4 IU/L (1.9–12.5 F)
FSH	↑	↑	1.5, 0.8 IU/L (3–20 F, 1–12 L)	4.1, 4.3, 4.9 IU/L (2.5–10.2 F)
E2	b13.6 pg/mL	b13.6 pg/mL		b10, 26, 42 pg/mL (11–165 F)
P				0.8 ng/dL (0.15–1.4)
Menarche	N/A	N/A	15 years	15 years
Menses	N/A	N/A	Scanty	Regular

Abbreviations: D4A—androstenedione, DHEA-S—Dehydroepiandrosterone-Sulfate, 17-OHP—17-hydroxyprogesterone, T—Testosterone, SHBG—sex hormone binding globulin, LH—luteinizing hormone, FSH—follicle stimulating hormone, E2—estradiol, P—progesterone.